“A New Generation of Headache Drugs” from Nature

“A New Generation of Headache Drugs” from Nature

Monoclonal antibodies and small-molecule antagonists that target CGRP or its receptor are already having a big impact on migraine. But they have the potential to do so much more. Peter Goadsby sat in the audience, intrigued. The Australian medical student had come to...

Pin It on Pinterest